Clinical trial
Natrecor in Pulmonary Hypertension
NCT00075179 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00075179 |
|---|---|
| Title | Natrecor in Pulmonary Hypertension |
| Official title | Phase IV, Open Labeled Study to Test the Effectiveness of Nesiritide in Reversing Pulmonary Hypertension in Patients Who Will be Undergoing CardioThoracic Surgery |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pulmonary Hypertension, Cancer, Lung Disease, Cardiothoracic Surgery |
| Intervention type | Drug, Procedure |
| Interventions | Nesiritide (Natrecor), Right Heart Catheterization |
| Enrollment | 15 |
| Start date | Dec 31, 2003 |
| Primary completion | Mar 28, 2006 |
| Completion | Mar 28, 2006 |
| First posted | Jan 6, 2004 |
| Last update posted | Nov 7, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: